XGN Competitors & Alternatives
Compare Exagen Inc with similar stocks in the same industry
Diagnostics & Research
XGN
Main Stock$7.88
Tradestie Score
56
Market Cap
$241.60M
Revenue Growth
0.2%
Analyst Upside
+34.2%
Top Competitors
40 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CDNA
CareDx, Inc.
|
$70.74
|
$798.40M | 33.3 | 30 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$20.13
|
$719.31M | - | 63 | Compare |
|
MYGN
Myriad Genetics Inc
|
$5.57
|
$719.23M | - | 39 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$34.37
|
$667.77M | - | 57 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$15.90
|
$612.76M | - | 57 | Compare |
|
FULC
Fulcrum Therapeutics, Inc. Common Stock
|
$3.70
|
$504.67M | - | 60 | Compare |
|
APYX
Apyx Medical Corporation Common Stock
|
$2.51
|
$81.31M | - | 60 | Compare |
|
BDSX
Biodesix, Inc. Common Stock
|
$23.93
|
$61.36M | - | 66 | Compare |
|
TELA
TELA Bio, Inc. Common Stock
|
$1.08
|
$59.42M | - | 63 | Compare |
|
VRCA
Verrica Pharmaceuticals Inc. Common Stock
|
$3.63
|
$41.94M | - | 54 | Compare |
More XGN Analysis
Data updated: Oct 22, 2026 | Industry: Diagnostics & Research (SIC 8071)
40 stocks in this industry